Product Reports Resources Pricing Login Book a demo

Ablynx

Biotech & Life Sciences · Ghent, Belgium · Founded 2001 · IPO 2007

Proprietary therapeutic proteins for treating life-threatening diseases

Valuation $4.80B
Revenue $135M
EBITDA $88M

Investors

11 investors on Ablynx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Gimv
Gilde Healthcare
Sofinnova Partners
Series B+ 8 investors entered at this stage
Flanders Institute for Biotechnology
Alta Partners
KBC
KBC
Vrije Universiteit Brussel
SR One
Alta Ventures
Abingworth

Global footprint

Where Ablynx has talent and traffic

Workforce by country
3 countries with
team presence
🇧🇪 Belgium97.5%
🇺🇸 United States1.2%
🇳🇱 Netherlands1.2%
3 countries shown
Web traffic by country
180 monthly visits
across markets
🇫🇷 France111.1%
Top 1 markets shown

Talent graph

The shape of Ablynx's talent

Dealroom maps Ablynx's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Ablynx's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$5.8B patent portfolio · 3,641 active families

Estimated portfolio value
$5.8B
120.2% of market cap · 94.3× larger than top peer ARIAD Pharmaceuticals ($61M)
3,641 active patent families
Where Ablynx innovates ArylCarbon atomCarboxylic acidChemistryCombinatorial chemistry

Where Ablynx concentrates vs peers

Each axis is a top-10 topic across Ablynx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ablynx

An AI-synthesized read of the highest-engagement posts about Ablynx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ablynx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.